Recently, overexpression of HK2 has been reported in various solid tumors, including colorectal cancer [10], hepatocellular carcinoma [11], ovarian cancer [12], and pancreatic cancer [13], indicating that HK2 plays an important role in the development and progression of cancer. This evidence concerns the gene HK2 and familial pancreatic carcinoma.